GILL JOHN

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
3 67% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GILL JOHN's trades of Altimmune Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
407.73
Quantity 14,091 +47.9%
Value US$2,736,292
Transaction date
Purchase
Price
60.95
Quantity 44,095 +23.6%
Value US$339,298
Transaction date
Sale
Price
301.11
Quantity 18,814 +0.5%
Value US$400,686
Transaction date
Planned sale
Price
11.92
Quantity 8,425 -42.9%
Value US$100,426
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-06 2026-04-06
B Purchase
14,091 +47.9%
407.73
US$2,736,292 		14,091 +47.9% 407.73 US$2,736,292
2025-12-23 2025-12-23
B Purchase
44,095 +23.6%
60.95
US$339,298 		44,095 +23.6% 60.95 US$339,298
2023-07-06 2022-08-12
S Sale
18,814 +0.5%
301.11
US$400,686 		18,814 +0.5% 301.11 US$400,686
2020-12-02 2020-11-30
PlS Planned sale
8,425 -42.9%
11.92
US$100,426 		8,425 -42.9% 11.92 US$100,426